Cancer Deaths
CANCER DEATHS
Cancer mortality refers to the number of deaths caused by cancer in a certain year in a specific geographical area.
The total number of deaths from cancer continues to increase. Between 1995 and 2018 there was a 20% increase from 1.2 million to 1.4 million deaths in Europe. However, the number of cancer deaths has increased at a slower pace than the number of cancer cases (50%).
Once population growth and ageing have been accounted for, the number of cancer deaths has in fact decreased since the mid 1990s.
For more information on cancer mortality in Europe, you can access the report here.
For cancer-specific mortality, please click on the cancer-specific icons below.
In line with incidence, cancer mortality has also increased over the past two decades although at a slower pace. For some countries cancer mortality rates are even declining.
Breast Cancer Mortality
In 2018, breast cancer mortality ranged from 24 cases per 100,000 inhabitants in Norway and 51.4 in Croatia, with the EU28+EFTA average at 37.7.
Lung Cancer Mortality
In 2018, lung cancer mortality for women ranged from 13.6 cases per 100,000 inhabitants in Cyprus to 69.6 in Hungary, with the EU28+EFTA average at 39. For men, mortality ranged from 36.9 in Sweden to 122 in Greece, with the EU28+EFTA average at 77.1.
Colon Cancer Mortality
In 2018, colorectal cancer mortality for women ranged from 14.8 per 100,000 in Cyprus to 43.5 in Hungary, with the EU28+EFTA average at 29.5. For men, mortality ranged from 24.3 per 100,000 in Luxembourg to 64.1 in Croatia, with the EU28+EFTA average at 38.2.
Prostate Cancer Mortality
In 2018, prostate cancer mortality ranged from 50.9 of 100,000 inhabitants in Estonia to 18.9 in Luxembourg, with the EU28+EFTA average at 32.8.
Melanoma Mortality
In 2018, melanoma mortality for women ranged from 1.9 cases per 100,000 inhabitants in Cyprus to 5.9 in Norway, with the EU28+EFTA average at 3.3. For men, it ranged from 2.4 in Iceland and Romania to 8.2 in Norway, with the EU28+EFTA average at 4.7.
Leukaemia Mortality
In 2018, leukaemia mortality for women ranged from 3.6 cases per 100,000 inhabitants in Iceland to 10.8 in Estonia, with the EU28+EFTA average at 7.9. For men, it ranged from 6.5 in Iceland and 14.4 in Greece, with the EU28+EFTA average at 10.7.
.
.
.
Multiple myeloma mortality – In 2018, multiple myeloma mortality for females ranged from 1.6 cases per 100,000 inhabitants in Bulgaria to 6.8 in Portugal, with the EU28+EFTA average at 4.6. For males, it ranged from 1.7 in Bulgaria to 6.9 in the Netherlands and Italy, with the EU28+EFTA average at 5.5.
.
.
.
Hodgkin’s lymphoma mortality – In 2018, Hodgkin’s lymphoma mortality for females ranged from 0 cases per 100,000 inhabitants in Iceland, Luxembourg and Malta to 1.6 in Greece, with the EU28+EFTA average at 0.4. For males, it ranged from 0 in Iceland, Luxembourg and Malta to 2.2 in Greece, with the EU28+EFTA average at 0.6.
.
.
.
Non-Hodgkin’s lymphoma mortality - In 2018, Non-Hodgkin’s lymphoma mortality for females ranged from 3 cases per 100,000 inhabitants in Iceland to 16.1 in Slovenia, with the EU28+EFTA average at 6.7. For males, it ranged from 3.9 in Romania to 12.6 in Slovenia, with the EU28+EFTA average at 8.7.
Ovarian Cancer Mortality
In 2018, ovarian cancer mortality ranged from 7.6 cases per 100,000 inhabitants in Portugal to 18.7 in Latvia, with the EU28+EFTA average at 12.1.
Pancreatic Cancer Mortality
In 2018, pancreatic cancer mortality for women ranged from 8.1 cases per 100,000 inhabitants in Cyprus to 23.1 in Finland, with the EU28+EFTA average at 18.1. For men, it ranged from 11.3 in Ireland to 24 in Germany, with the EU28+EFTA average at 19.3.